Ingrid Ottevaere

Title: The Innovative Contributions of Ingrid Ottevaere

Introduction

Ingrid Ottevaere is a notable inventor based in Nazareth, Belgium. She has made significant contributions to the field of biochemistry, particularly in the development of immunoglobulin single variable domains. Her work focuses on creating amino acid sequences that can effectively bind to serum albumin, which has important implications in therapeutic applications.

Latest Patents

Ingrid Ottevaere holds a patent for her invention titled "Serum albumin binding immunoglobulin single variable domains." This invention relates to amino acid sequences that can bind to serum albumin. Specifically, it involves heavy-chain immunoglobulin single variable domains that can bind to serum albumin. The patent also encompasses proteins, polypeptides, and other constructs that include at least one of the immunoglobulin single variable domains described in her work.

Career Highlights

Ingrid Ottevaere is associated with Ablynx N.V., a company known for its innovative approaches in biopharmaceuticals. Her role at Ablynx has allowed her to contribute to groundbreaking research and development in the field. With one patent to her name, she has established herself as a key figure in her area of expertise.

Collaborations

Ingrid collaborates with talented professionals in her field, including her coworkers Stephanie Staelens and Soren Steffensen. These collaborations enhance the research environment and foster innovation within the company.

Conclusion

Ingrid Ottevaere's work exemplifies the spirit of innovation in biochemistry. Her contributions, particularly in serum albumin binding immunoglobulin single variable domains, highlight the importance of her research in advancing therapeutic solutions.